| Catalog No | Product Description | CAS No. | Purity | Structural Formula |
|---|---|---|---|---|
| BP2057 |
Continentalic acid
Continentalic acid and kaurenoic acid are quality control markers in Aralia continentalis. Continentalic acid has anti-inflammatory, anti-cancer, and anti-bacterial activities, it shows moderate cytotoxicity against A-549 (lung), THP-1 (leukemia) and MCF-7 (breast) cell lines; it has minimum inhibitory concentrations (MICs) of approximately 8-16 microg/mL against S. aureus, including the MSSA and MRSA standard strains.
|
19889-23-7 | 98% |
|
| BP0708 |
Hederacoside C
Hederacoside C is one of the active ingredients in Hedera helix leaf extract (Ivy Ex.) and AG NPP709, a new botanical drug to treat acute respiratory infection and chronic inflammatory bronchitis. Hederacoside C has antispasmodic activity. Hederacoside C is a potent competitive inhibitor for serine protease porcine pancreatic elastase, shows comparable IC 50 value is 40.6 uM; it also non-competitively inhibits hyaluronidase activity in a dose- dependent fashion, shows comparable IC 50 value is 280.4 uM. Kalopanaxsaponin B is a triterpenoid saponin with hederagenin as the aglycone part. It has been isolated from the stem bark of Kalopanax pictus. It has a role as an anti-inflammatory agent and a plant metabolite. It is a pentacyclic triterpenoid, a carboxylic ester and a triterpenoid saponin. It is functionally related to a hederagenin.
|
14216-03-6 | 98% |
|
| SBP02669 |
(+)-Lyoniresinol 9'-O-glucoside
(+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside is a lignan that is (+)-lyoniresinol substituted by a beta-D-glucopyranosyl moiety at position 3 via a glycosidic linkage. Isolated from the root barks of Stemmadenia minima and Lycium chinense, it exhibits antimicrobial activities. It has a role as a metabolite, an antibacterial agent and an antifungal agent.
|
87585-32-8 | 98% |
|
| BP3356 |
Schisandrone
Schisandrone has strong activities of anti-oxidation, effectively scavenges hydroxyl radical and superoxide anion, and has protective effects on cells under active oxygen stress state. Schisandrone can significantly decrease phosphorylation levels of Tau protein at 396, 262 sites, and relieve neuronal injury, but the phosphorylation level does not reach a negative cell level; it can suppress the Aβ-induced oxidative stress and inflammatory reaction through influencing NF-κB signaling pathway, exerting its protective effect on Alzheimer disease.
|
98619-25-1 | 98% |
|
| BP4076 |
(-)-corynoxidine
Corynoxidine exhibits antibacterial activities against Staphylococcus aureus and methicillin-resistant S. aureus strains. It inhibits acetylcholinesterase activity in a dose-dependent manner, and the IC50 value of 89.0 microM.
|
57906-85-1 | 98% |
|
| SBP02855 | 87562-14-9 |
|
||
| SBP02663 | 77263-06-0 |
|
||
| BP0409 | 142409-09-4 |
|
||
| BP0938 | 111-82-0 |
|
||
| SBP02853 | 464-45-9 |
|
||
| SBP02873 | 36357-32-1 |
|
||
| SBP02743 | 21852-80-2 |
|
||
| SBP02904 | 72500-11-9 |
|
||
| SBP02698 |
3,4,5-trimethoxybenzoic acid
3,4,5-trimethoxybenzoic acid is a benzoic acid derivative carrying 3-, 4- and 5-methoxy substituents. It has a role as a plant metabolite, a human xenobiotic metabolite and a human urinary metabolite. It is a member of benzoic acids and a member of methoxybenzenes. It is functionally related to a benzoic acid. It is a conjugate acid of a 3,4,5-trimethoxybenzoate.
|
118-41-2 | 98% |
|
| BP0376 | 24394-09-0 |
|
||
| SBP02935 | 67685-22-7 |
|
||
| SBP01667 | 179388-53-5 |
|
||
| SBP00401 | 70110-60-0 |
|
||
| SBP02886 | 72959-46-7 |
|
||
| SBP02959 | 178765-54-3 |
|
Shenshuai
Wenjing
Hedandan